Human islets of Langerhans express fas ligand and undergo apoptosis in response to interleukin-1β and fas ligation

Diabetes

Volumn 47, Issue 5, 1998, Pages 727-732

  Loweth, Anne C ^a   Williams, Gwyn T ^a   James, Roger F L ^b   Scarpello, John H B ^a   Morgan, Noel G ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CELL DEATH; CELL KILLING; CELL LOSS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; LANGERHANS CELL; LIGAND BINDING; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0031897507     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.5.727     Document Type: Article

References (46)

1. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen, AE, Bjerre U, and Lorenzen T On the pathogenesis of IDDM. Diabetologia 37 (Suppl. 2):S82-S89, 1994
2. Boitard C, Larger E, Timsit J, Sempe P, Bach JF: IDDM: an islet or autoimmune disease? Diabetologia 37 (Suppl. 2):S90-S98, 1994
3. Kahn CR: New concepts in the pathogenesis of diabetes mellitus. Adv Internal Med 41:285-321, 1996
4. Homo-Delarche F, Boitard C: Autoimmune diabetes: the role of the islets of Langerhans. Immunol Today 17:456-460, 1996
5. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 85:291-297, 1996
6. Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D: Checkpoints in the progression of autoimmune disease: lessons from diabetes models, Proc Natl Acad Sci USA 93:2260-2263, 1996
7. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA, Matis LA: The role of Fas in autoimmune diabetes. Cell 89:17-24, 1997
8. O'Brien BA, Harmon BV, Cameron DP, Allan DJ: Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol 178:176-181, 1996
9. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerstrom C, Andersson A: Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci USA 91:9253-9256, 1994
10. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N: The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875-890, 1996
11. Wyllie AH: The genetic regulation of apoptosis. Curr Opin Genet Dev 5:97-104, 1995
12. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462, 1995
13. Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC, Williams GT: Apoptosis: molecular regulation of cell death. Eur J Biochem 236:1-26, 1996
14. Benoist C, Mathis D: Cell death mediators in autoimmune diabetes: no shortage of suspects. Cell 89:1-3, 1997
15. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
16. Vandenabeele P, Declerq W, Beyaert R, Fiers W: Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 5:392-400, 1995
17. Mandrup-Poulsen T: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
18. Stassi G, Todaro M, Richiusa P, Giordano M, Mattina A, Sbriglia MS, Lo Monte A, Buscemi G, Galluzzo A, Giordano C: Expression of apoptosis-inducing CD95 (Fas/Apo 1) on human β-cells by flow cytometry and cultured in vitro. Transplantation Proc 27:3271-3275, 1995
19. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K: Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39:1306-1312, 1996
20. Itoh N, Imagawa A, Hanafusa T, Waguri M, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsuzawa Y: Requirement for Fas in the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 186:61:3-618, 1997
21. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963, 1996
22. Kang S-M, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S: Fas ligand in islets of Langerhans does not confer Immune privilege and instead targets them for rapid destruction. Nature. Med 3:738-743, 1997
23. Stassi G, De Maria R, Trucco G, Rudert W, Testi R, Galluzzo A, Giordano C, Trucco M: Nitric oxide primes pancreatic β-cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186:1193-1200, 1997
24. Lake SP, Bassett PD, Larkins A, Revell J, Walczak K, Chamberlain J, Rumford GM, London NJM, Veitch PS, Bell PRF, James RFL Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes 38 (Suppl. 1):43-45, 1989
25. Zhu H, Fearnhead HO, Cohen GM: An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.1 cells. FEBS Lett 374:303-308, 1995
26. Longthorne VL, Williams GT: Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J 16:3805-3812, 1997
27. Southern C, Schulster D, Green IC: Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-alpha by an Larginine-dependent nitric oxide generating mechanism. FEBS Lett 270:42-44, 1990
28. Cunningham JR, Green IC: Cytokines, nitric oxide and insulin-secreting cells. Growth Regulation 4:173-180, 1994
29. McDaniel ML, Kwon G, Hill JR, Marshall CA, Corbett JA: Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med 211:24-32, 1996
30. Ankarcrona M, Dypbukt JM, Brune B, Nicotera P: Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213:172-177, 1904
31. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N: Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44:733-738, 1996
32. Loweth AC, Williams GT, Scarpello JHB, James RFL, Morgan NG: Human pancreatic islets display reduced sensitivity to nitric oxide-induced apoptosis compared to rodent clonal B-cell lines. Diabetes Res 31:231-241, 1996
33. Di Matteo MA, Loweth AC, Thomas S, Mabley JG, Morgan NG, Thorpe JR, Green IC: Superoxide, nitric oxide, peroxynitrite and cytokine combinations all cause functional impairment and morphological changes in rat islets of Langerhans and insulin-secreting cell lines, but dictate cell death by different mechanisms. Apoptosis 2:164-177, 1997
34. Loweth AC, Williams GT, Scarpello JHB, Morgan NG: Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15. FEBS Lett 400:285-288, 1997
35. Lau HT, Yu M, Fontana A, Stoeckert CJ: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109-112, 1996
36. Allison J, Georgiou HM, Strasser A, Vaux DL: Transgenic expression of CD95 ligand on islet β-cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Sci, Acad 94:3943-3947, 1997
37. Korbutt GS, Elliott JF, Rajotte RV: Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46:317-322, 1997
38. Iwahashi H, Hanafusa T, Eguchi Y, Nakajima H, Miyagawa J, Itoh N, Tomita K, Namba M, Kumajima M, Noguchi T, Tsujimoto Y, Matsuzawa Y. Cytokine-induced apoptotic cell death in a mouse pancreatic beta cell line: inhibition by Bcl-2. Diabetologia 39:530-536, 1996
39. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL: Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 71:152-156, 1990
40. Kawahara DJ, Kenney JS: Species differences in human and rat islet sensitivity to human cytokines. Cytokine 3:117-124, 1991
41. Eizirik DL, Welsh N, Hellerstrom C: Predominance of stimulatory effects of interleukin-1β on isolated human pancreatic islets. J Clin Endocrinol Metab 76:399-403, 1993
42. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL: Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138:2610-2614, 1997
43. Corbett JA, Sweetland MA, Wang JL, Lancaster JR, McDaniel ML: Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 90:1731-1735, 1993
44. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 377:630-632, 1996
45. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192, 1995
46. Vaux DL: Ways around rejection. Nature 377:576-577, 1995